JP2024535145A5 - - Google Patents
Info
- Publication number
- JP2024535145A5 JP2024535145A5 JP2024513977A JP2024513977A JP2024535145A5 JP 2024535145 A5 JP2024535145 A5 JP 2024535145A5 JP 2024513977 A JP2024513977 A JP 2024513977A JP 2024513977 A JP2024513977 A JP 2024513977A JP 2024535145 A5 JP2024535145 A5 JP 2024535145A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- mva
- mirblock
- mirna target
- eukaryotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21194940.9 | 2021-09-03 | ||
| EP21194940 | 2021-09-03 | ||
| PCT/EP2022/074510 WO2023031428A1 (en) | 2021-09-03 | 2022-09-02 | Utilization of micro-rna for downregulation of cytotoxic transgene expression by modified vaccinia virus ankara (mva) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535145A JP2024535145A (ja) | 2024-09-27 |
| JP2024535145A5 true JP2024535145A5 (enExample) | 2025-08-12 |
Family
ID=77640525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513977A Pending JP2024535145A (ja) | 2021-09-03 | 2022-09-02 | 改変ワクシニアウイルスアンカラ（ｍｖａ）による細胞傷害性導入遺伝子発現を下方調節するためのマイクロｒｎａの利用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240392257A1 (enExample) |
| EP (1) | EP4396333A1 (enExample) |
| JP (1) | JP2024535145A (enExample) |
| KR (1) | KR20240051214A (enExample) |
| CN (1) | CN118234850A (enExample) |
| AU (1) | AU2022338199A1 (enExample) |
| CA (1) | CA3230406A1 (enExample) |
| IL (1) | IL311078A (enExample) |
| MX (1) | MX2024002641A (enExample) |
| WO (1) | WO2023031428A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024188801A1 (en) * | 2023-03-10 | 2024-09-19 | Bavarian Nordic A/S | Use of quail cell lines for poxvirus production |
| WO2024245722A2 (en) * | 2023-05-26 | 2024-12-05 | Probiogen Ag | Rapid selection system for the generation of recombinant enveloped viruses |
| AU2024396470A1 (en) * | 2023-12-08 | 2026-06-04 | Bavarian Nordic A/S | Downregulation of yield-reducing transgenes expressed by poxvirus |
| WO2025153852A1 (en) * | 2024-01-17 | 2025-07-24 | 1. Revvity Gene Delivery Gmbh | Production of viral vectors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU230198B1 (hu) | 2000-11-23 | 2015-10-28 | Bavarian Nordic A/S | Módosított Vacciniavírus Ankara-variáns |
| EP1456230A2 (en) | 2001-12-04 | 2004-09-15 | Bavarian Nordic A/S | Flavivirus ns1 subunit vaccine |
| US20060185027A1 (en) * | 2004-12-23 | 2006-08-17 | David Bartel | Systems and methods for identifying miRNA targets and for altering miRNA and target expression |
| US20100261175A1 (en) * | 2007-06-15 | 2010-10-14 | Exiqon A/S | Use of short oligonucleotides for reagent redundancy experiments in rna functional analysis |
| US8883995B2 (en) * | 2009-03-06 | 2014-11-11 | Icahn School Of Medicine At Mount Sinai | Live attenuated influenza virus vaccines comprising microRNA response elements |
| GB2469043B (en) * | 2009-03-30 | 2011-02-23 | Lotus Car | A reheated gas turbine system having a fuel cell |
| US20130280215A1 (en) * | 2011-10-18 | 2013-10-24 | Geovax, Inc. | Mva vectors expressing polypeptides and having high level production in certain cell lines |
| SI2879702T1 (sl) * | 2012-08-01 | 2020-02-28 | Bavarian Nordic A/S | Cepivo na osnovi rekombinantnega modificiranega virusa vakcinacije Ankara (MVA) proti respiratornemu sincitialnemu virusu (RSV) |
| MX380483B (es) | 2012-10-28 | 2025-03-12 | Bavarian Nordic As | Promotor pr13.5 para respuestas de anticuerpos y linfocitos t fuertes. |
| CN106636310B (zh) * | 2015-10-30 | 2020-06-02 | 益善生物技术股份有限公司 | 前列腺癌相关microRNA检测试剂盒 |
| CN106636315B (zh) * | 2015-10-30 | 2020-06-02 | 益善生物技术股份有限公司 | 淋巴瘤相关microRNA检测试剂盒 |
-
2022
- 2022-09-02 JP JP2024513977A patent/JP2024535145A/ja active Pending
- 2022-09-02 CN CN202280073591.8A patent/CN118234850A/zh active Pending
- 2022-09-02 WO PCT/EP2022/074510 patent/WO2023031428A1/en not_active Ceased
- 2022-09-02 MX MX2024002641A patent/MX2024002641A/es unknown
- 2022-09-02 IL IL311078A patent/IL311078A/en unknown
- 2022-09-02 CA CA3230406A patent/CA3230406A1/en active Pending
- 2022-09-02 EP EP22772951.4A patent/EP4396333A1/en active Pending
- 2022-09-02 KR KR1020247010053A patent/KR20240051214A/ko active Pending
- 2022-09-02 AU AU2022338199A patent/AU2022338199A1/en active Pending
- 2022-09-02 US US18/688,756 patent/US20240392257A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6291467B2 (ja) | 組換えウイルス発現のためのプロモーター | |
| RU2233333C2 (ru) | Вирусные векторы и их применение в генной терапии | |
| Hanke et al. | Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice | |
| Wang et al. | A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis | |
| AU2020264302B2 (en) | Recombinant Orf virus vector | |
| JP2873880B2 (ja) | ポックスウイルス成分の組み合わせにもとづく類属免疫誘導剤、その製造方法 | |
| CN106232813A (zh) | 预防减蛋综合征(eds)的疫苗 | |
| US20240392257A1 (en) | Utilization of Micro-RNA for Downregulation of Cytotoxic Transgene Expression by Modified Vaccinia Virus Ankara (MVA) | |
| WO2022071513A1 (ja) | ＳＡＲＳ－ＣｏＶ－２に対する改良型ＤＮＡワクチン | |
| KR0181976B1 (ko) | 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학 분야에서 이들을 사용하는 방법 | |
| CN1289682C (zh) | 通过使用牛痘ati启动子表达改良的安卡拉痘苗病毒中的基因 | |
| CN103805635B (zh) | 一种基于J亚群禽白血病病毒env基因保守序列的siRNA重组干扰载体及其制备方法和应用 | |
| CN117603920A (zh) | 一种表达血清11型禽腺病毒Fiber蛋白的重组血清4型禽腺病毒及其构建方法和应用 | |
| JP2000157289A5 (enExample) | ||
| Webster | Potential advantages of DNA immunization for influenza epidemic and pandemic planning | |
| JP6373601B2 (ja) | アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド | |
| KR101329348B1 (ko) | 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스 | |
| CN103937833B (zh) | 一种基于J亚群禽白血病病毒LTR基因保守序列的siRNA重组干扰载体及其制备方法和应用 | |
| CN103966259B (zh) | 一种基于J亚群禽白血病病毒gag基因保守序列的siRNA重组干扰载体及其制备方法和应用 | |
| CN1955301A (zh) | 一种鸡痘病毒通用转移载体、重组鸡痘病毒及其制备方法 | |
| CN102512662B (zh) | 含有柯萨奇b3病毒2b蛋白中36-83位氨基酸基序的蛋白质及其应用 | |
| JP2024543954A5 (enExample) | ||
| JP2023549561A (ja) | 最適化されたユニバーサルインフルエンザワクチンの設計、それらの設計及び使用 | |
| JP2020529391A5 (enExample) | ||
| WO2004108939A2 (en) | Bav packaging regions and e1 transcriptional control regions |